PFG Investments »

Lineage Cell Therapeutics In shares owned by PFG Investments

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by PFG Investments from 13F filings

Historical chart of PFG Investments investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by PFG Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by PFG Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $31k 21k 1.48
2023-12-31 $22k 20k 1.09
2023-09-30 $24k 20k 1.18
2023-06-30 $29k 20k 1.41
2023-03-31 $30k 20k 1.50

More positions owned by PFG Investments

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Vanguard Bd Index Fds Intermed Term (BIV)
Pimco Dynamic Income SHS (PDI)
Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for PFG Investments

Top funds holding Lineage Cell Therapeutics In

Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Barclays
Royal Bank of Canada
Squarepoint Ops
Jane Street

View all funds holding Lineage Cell Therapeutics In